Takagi Hironori 高木玄教

… Alternative Names

高木玄教タカギヒロノリ

Less

Researcher Number	90834325
Affiliation (Current)	2025: 福島県立医科大学, 医学部, 博士研究員
Affiliation (based on the past Project Information) *help	2023: 福島県立医科大学, 医学部, 博士研究員 2021: 福島県立医科大学, 医学部, 客員研究員 2020: 福島県立医科大学, 医学部, 助手 2019: 福島県立医科大学, 医学部, 病院助手
Review Section/Research Field	Principal Investigator Basic Section 55040:Respiratory surgery-related
Keywords	Principal Investigator Radioimmunotherapy / 211At(Astatine) / HER3 / Lung Cancer / astatine / radioimmunotherapy / Notch ligand / DLK1 / lung cancer

非小細胞肺癌のHER3を標的とした211Atによる免疫放射線療法の開発Principal Investigator
- Principal Investigator
  
  高木玄教
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Fukushima Medical University
Assessment of Delta-like 1 homolog (DLK1) expression as a therapeutic target in small cell lung cancer and its application to radioimmunotherapyPrincipal Investigator
- Principal Investigator
  
  Takagi Hironori
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Fukushima Medical University

All 2021

All Journal Article Presentation

[Journal Article] CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma2021
- Author(s)
  Watanabe Masayuki、Higashi Tomohito、Ozeki Kana、Higashi Atsuko Y.、Sugimoto Kotaro、Mine Hayato、Takagi Hironori、Ozaki Yuki、Muto Satoshi、Okabe Naoyuki、Matsumura Yuki、Hasegawa Takeo、Shio Yutaka、Suzuki Hiroyuki、Chiba Hideki
- Journal Title
  
  Scientific Reports
  
  Volume: 11 Issue: 1 Pages: 12554-12554
- DOI
  10.1038/s41598-021-91464-0
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K18223, KAKENHI-PROJECT-19K18224, KAKENHI-PROJECT-19K09310, KAKENHI-PROJECT-21K06950
[Journal Article] Efficacy of Immune-checkpoint Inhibitors as the Peri-operative Treatment for Resectable Non-small-cell Lung Cancer2021
- Author(s)
  鈴木弘行、猪俣頌、山口光、峯勇人、高木玄教、尾崎有紀、渡部晶之、井上卓哉、福原光朗、山浦匠、武藤哲史、岡部直行、松村勇輝、長谷川剛生、大杉純、星野実加、樋口光徳、塩豊
- Journal Title
  
  Haigan
  
  Volume: 61 Issue: 7 Pages: 919-923
- DOI
  10.2482/haigan.61.919
- NAID
  130008136549
- ISSN
  0386-9628, 1348-9992
- Year and Date
  2021-12-20
- Language
  Japanese
- Open Access
- Data Source
  KAKENHI-PROJECT-19K18223, KAKENHI-PROJECT-19K09310, KAKENHI-PROJECT-20K17754
[Journal Article] Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)2021
- Author(s)
  Takagi Hironori、Zhao Songji、Muto Satoshi、Yokouchi Hiroshi、Nishihara Hiroshi、Harada Toshiyuki、Dosaka-Akita Hirotoshi、Nakamura Koji、Inano Akihiro、Isobe Hiroshi、Suzuki Hiroyuki、et al.
- Journal Title
  
  Lung Cancer
  
  Volume: 153 Pages: 134-142
- DOI
  10.1016/j.lungcan.2021.01.014
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09310, KAKENHI-PROJECT-19K18223
[Journal Article] CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC2021
- Author(s)
  Muto Satoshi、Inomata Sho、Yamaguchi Hikaru、Mine Hayato、Takagi Hironori、Ozaki Yuki、Watanabe Masayuki、Inoue Takuya、Yamaura Takumi、Fukuhara Mitsuro、Okabe Naoyuki、Matsumura Yuki、Hasegawa Takeo、Osugi Jun、Hoshino Mika、Higuchi Mitsunori、Shio Yutaka、Suzuki Hiroyuki
- Journal Title
  
  Anticancer Research
  
  Volume: 41 Issue: 12 Pages: 6267-6272
- DOI
  10.21873/anticanres.15447
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K18223, KAKENHI-PROJECT-19K09310, KAKENHI-PROJECT-21K08890, KAKENHI-PROJECT-20K17754
[Journal Article] The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study2021
- Author(s)
  Fukuhara Mitsuro、Muto Satoshi、Inomata Sho、Yamaguchi Hikaru、Mine Hayato、Takagi Hironori、Ozaki Yuki、Watanabe Masayuki、Inoue Takuya、Yamaura Takumi、Okabe Naoyuki、Matsumura Yuki、Hasegawa Takeo、Osugi Jun、Hoshino Mika、Higuchi Mitsunori、Shio Yutaka、Suzuki Hiroyuki
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 71 Issue: 5 Pages: 1129-1137
- DOI
  10.1007/s00262-021-03067-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K18223, KAKENHI-PROJECT-21K08890, KAKENHI-PROJECT-20K17754, KAKENHI-PROJECT-19K09310
[Presentation] Study of Relationship Between Proportion of CTLA-4 Positive Tregs in Tumor Infiltrating Lymphocytes and PD-L1 TPS2021
- Author(s)
  Muto Satoshi、Inomata Syo、Yamaguchi Hikaru、Mine Hayato、Takagi Hironori、Ozaki Yuki、Okabe Naoyuki、Matsumura Yuki、Shio Yutaka、Suzuki Hiroyuki
- Organizer
  IASLC 2020 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18223
[Presentation] PD1-Positive Tertiary Lymphoid Structure as a Predictive Factor of Durable Clinical Effect in Immunotherapy for NSCLC2021
- Author(s)
  Matsumura Yuki、Inomata Sho、Yamaguchi Hikaru、Mine Hayato、Takagi Hironori、Watanabe Masayuki、Ozaki Yuki、Muto Satoshi、Okabe Naoyuki、Shio Yutaka、Suzuki Hiroyuki
- Organizer
  IASLC 2021 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18223

1. 鈴木弘行

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Takagi Hironori 高木 玄教

高木 玄教 タカギ ヒロノリ

Research Projects

Research Products

Co-Researchers

非小細胞肺癌のHER3を標的とした211Atによる免疫放射線療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Assessment of Delta-like 1 homolog (DLK1) expression as a therapeutic target in small cell lung cancer and its application to radioimmunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy of Immune-checkpoint Inhibitors as the Peri-operative Treatment for Resectable Non-small-cell Lung Cancer2021

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] Study of Relationship Between Proportion of CTLA-4 Positive Tregs in Tumor Infiltrating Lymphocytes and PD-L1 TPS2021

Author(s)

Organizer

Data Source

[Presentation] PD1-Positive Tertiary Lymphoid Structure as a Predictive Factor of Durable Clinical Effect in Immunotherapy for NSCLC2021

Author(s)

Organizer

Data Source

Takagi Hironori 高木玄教

高木玄教タカギヒロノリ